GenSpera, Inc.

Revolutionizing Cancer Targeting and Treatment

GenSpera's multiple candidates tackle challenging areas in oncology

View Product Pipeline

About

About

GenSpera is a leader in developing prodrug therapeutics for the treatment of cancer, harnessing a novel biomedical technology platform to deliver a powerful toxin directly to tumors

More About Genspera
Team

Team

GenSpera's leadership and scientific teams have deep industry experience as well as clinical development, and successfully bring together the world's leading researchers in oncology.

View Leadership
Technology

Technology

Developed at Johns Hopkins University and the University of Copenhagen, GenSpera's patented targeting technology precisely tracks tumor activity and has potential for treating many kinds of cancer.

Technology
Learn

Learn

Learn about GenSpera's work with mipsagargin and its ongoing clinical development work.

View Video

Sign up for Email Alerts

Be the first to receive breaking news

Sign up Today